Efficacy and Safety of Parecoxib on Morphine Patient-controlled Epidural Analgesia (PCEA) After G… (NCT01566669) | Clinical Trial Compass
CompletedNot Applicable
Efficacy and Safety of Parecoxib on Morphine Patient-controlled Epidural Analgesia (PCEA) After Gynecologic Surgery
China294 participantsStarted 2009-06
Plain-language summary
The purpose of this study is to determine the effects of parecoxib in combination with epidural morphine in providing analgesia for patients undergoing gynecological surgery.
Who can participate
Age range18 Years – 65 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* women scheduled for elective gynecological surgery under combined spinal-epidural anesthesia
Exclusion Criteria:
* contraindications for CSE placement
* known allergy, sensitivity, or contraindication to opioid and nonopioid analgesic drugs
* history of bleeding disorders, peptic ulceration, or anticoagulant use within the past month
* current pregnancy or breastfeeding
* history of known or suspected drug abuse
* unable to understand the use of pain assessment scales and the PCA device
* Patient with asthma or bronchospasm, requiring treatment with glucocorticoids
* poorly controlled hypertension or diabetes, a chronic or acute renal or hepatic disorder, or inflammatory bowel disease
* patients had taken antidepressants, narcotic analgesics, antihistamines, anxiolytics, hypnotics, sedatives, NSAIDs, or corticosteroids up to 24 h before receipt of the study medication